Shu Feng Zhang

Presidente en Beijing Biostar Pharmaceuticals Co. Ltd. .

55 años

Consumer Services

Health Technology

Perfil

Shu Feng Zhang is currently the Chairman-Supervisory Board at Beijing Biostar Pharmaceuticals Co. Ltd.
He started this position in 2021.
Prior to his current role, he obtained an MBA from Tsinghua University in 1999.

Cargos activos de Shu Feng Zhang

Empresas	Cargo	Inicio
Beijing Biostar Pharmaceuticals Co. Ltd. Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China.	Presidente	01/03/2021

Todos los cargos activos de Shu Feng Zhang

Formación de Shu Feng Zhang.

Tsinghua University

Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Shu Feng Zhang.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
Beijing Biostar Pharmaceuticals Co. Ltd. Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China.	Health Technology